↓ Skip to main content

Wiley Online Library

A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements.

Overview of attention for article published in Drug Testing and Analysis, October 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#6 of 981)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
25 news outlets
blogs
4 blogs
twitter
85 tweeters
facebook
16 Facebook pages
wikipedia
1 Wikipedia page
googleplus
3 Google+ users
video
1 video uploader

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
52 Mendeley
citeulike
1 CiteULike
Title
A synthetic stimulant never tested in humans, 1,3-dimethylbutylamine (DMBA), is identified in multiple dietary supplements.
Published in
Drug Testing and Analysis, October 2014
DOI 10.1002/dta.1735
Pubmed ID
Authors

Cohen PA, Travis JC, Venhuis BJ, Cohen, Pieter A., Travis, John C., Venhuis, Bastiaan J.

Abstract

A synthetic stimulant never before studied in humans, 1,3-dimethylbutylamine (DMBA), was suspected of being present in dietary supplements. DMBA is an analogue of the pharmaceutical stimulant, 1,3-dimethylamylamine (DMAA), which was recently banned by the US Food and Drug Administration. We obtained all dietary supplements sold by US distributors that listed an ingredient on the label, such as AMP Citrate, that might be a marketing name for DMBA. Supplements were analyzed for the presence and quantity of DMBA. Fourteen supplements met our inclusion criteria and were analyzed by two separate laboratories using ultra high performance liquid chromatography (UHPLC) - mass spectrometry and a reference standard. The identity of DMBA was confirmed in 12 supplements in the range of 13 to 120 mg DMBA per serving. Following recommendations on the supplement label for maximum daily intake, customers would consume from 26 to 320 mg of DMBA per day. Supplements containing DMBA were marketed to improve athletic performance, increase weight loss and enhance brain function. DMBA has never before been detected in supplements. The stimulant has never been studied in humans; its efficacy and safety are entirely unknown. Regulatory agencies should act expeditiously to warn consumers and remove DMBA from all dietary supplements. Copyright © 2014 John Wiley & Sons, Ltd.

Twitter Demographics

The data shown below were collected from the profiles of 85 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 2%
Unknown 51 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 19%
Researcher 10 19%
Student > Bachelor 10 19%
Other 4 8%
Student > Ph. D. Student 3 6%
Other 8 15%
Unknown 7 13%
Readers by discipline Count As %
Chemistry 15 29%
Agricultural and Biological Sciences 8 15%
Biochemistry, Genetics and Molecular Biology 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Sports and Recreations 3 6%
Other 10 19%
Unknown 8 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 295. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2016.
All research outputs
#53,120
of 15,647,728 outputs
Outputs from Drug Testing and Analysis
#6
of 981 outputs
Outputs of similar age
#702
of 213,225 outputs
Outputs of similar age from Drug Testing and Analysis
#1
of 16 outputs
Altmetric has tracked 15,647,728 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 981 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 213,225 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.